<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/pbm-reform-legislation-reshape-pharmacy-business-models</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-25T08:47:02.271Z</news:publication_date>
      <news:title>PBM Reform Legislation Set to Reshape Pharmacy Business Models</news:title>
      <news:keywords>PBM reform, pharmacy reimbursement, healthcare policy, pharmacy business models, drug pricing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/merck-pd1-vegf-bispecific-oncology-data</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-24T14:10:49.752Z</news:publication_date>
      <news:title>Merck Unveils First PD-1xVEGF Bispecific Data in Oncology Push</news:title>
      <news:keywords>bispecific-antibodies, immunotherapy, merck, oncology, clinical-trials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-approves-idvynso-doravirine-islatravir-hiv-treatment</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-23T14:10:50.072Z</news:publication_date>
      <news:title>FDA Approves Idvynso: First Once-Daily Doravirine/Islatravir Combo</news:title>
      <news:keywords>HIV treatment, FDA approval, antiretroviral therapy, single-tablet regimen, doravirine</news:keywords>
    </news:news>
  </url>
</urlset>